Menu
13/01/2009
New Guidelines 'May Do Little To Improve Availability Of Expensive Drugs'
New guidelines to help improve access to end-of-life drugs for terminally ill patients are unlikely to lead to acceptance of all the drugs provisionally refused, argues a senior researcher on the website, BMJ.com today.
James Raftery, Professor of Health Technology Assessment at Southampton University, says that the new arrangements from the National Institute for Health and Clinical Excellence (NICE) will do little to improve availability of expensive drugs and may result in other patient groups being denied treatment.
During 1999-2008, NICE rejected 11 drugs on the grounds of cost effectiveness (their cost per quality adjusted life year or QALY was well above NICE’s threshold of £30,000). A QALY is a combined measure of quantity and quality of life.
These decisions sparked ethical, legal and political dilemmas, and prompted a review which recommended that NICE should revise its cost effectiveness threshold for end of life drugs. The new advice applies to treatments that affect small numbers of patients who are not expected to live more than 24 months, and that offer demonstrable survival benefits (at least an extra three months of life) compared with current NHS practice.
Professor Raftery examined the effect the new arrangements would have had on all cancer drugs that NICE has refused or proposed to refuse because of cost effectiveness.
He found that few of the rejected drugs would qualify under the new criteria, with most failing to meet the criterion that no alternative treatment with comparable benefits existed.
He also warns that making an exception for any group sets a precedent for other groups, and that setting the threshold higher for some groups within a fixed overall budget results in other patient groups being denied treatment.
He concludes: "NICE will celebrate its 10th birthday in 2009 having had to make a major change in its methods. Its attempt to minimise the effects of these changes will no doubt be tested in future appeals against its findings."
(JM/BMcC)
James Raftery, Professor of Health Technology Assessment at Southampton University, says that the new arrangements from the National Institute for Health and Clinical Excellence (NICE) will do little to improve availability of expensive drugs and may result in other patient groups being denied treatment.
During 1999-2008, NICE rejected 11 drugs on the grounds of cost effectiveness (their cost per quality adjusted life year or QALY was well above NICE’s threshold of £30,000). A QALY is a combined measure of quantity and quality of life.
These decisions sparked ethical, legal and political dilemmas, and prompted a review which recommended that NICE should revise its cost effectiveness threshold for end of life drugs. The new advice applies to treatments that affect small numbers of patients who are not expected to live more than 24 months, and that offer demonstrable survival benefits (at least an extra three months of life) compared with current NHS practice.
Professor Raftery examined the effect the new arrangements would have had on all cancer drugs that NICE has refused or proposed to refuse because of cost effectiveness.
He found that few of the rejected drugs would qualify under the new criteria, with most failing to meet the criterion that no alternative treatment with comparable benefits existed.
He also warns that making an exception for any group sets a precedent for other groups, and that setting the threshold higher for some groups within a fixed overall budget results in other patient groups being denied treatment.
He concludes: "NICE will celebrate its 10th birthday in 2009 having had to make a major change in its methods. Its attempt to minimise the effects of these changes will no doubt be tested in future appeals against its findings."
(JM/BMcC)
Related UK National News Stories
Click here for the latest headlines.
29 May 2015
23 Charged With Drug Offences Following Raids
More than 20 people have been charged with drug offences following a number of raids carried out in London, Gravesend, Dover and Deal. A total of 23 people were arrested during twenty raids carried out over three days. The suspects, ranging in age from 17 to 52, have all been charged in connection with the supply of class A drugs.
23 Charged With Drug Offences Following Raids
More than 20 people have been charged with drug offences following a number of raids carried out in London, Gravesend, Dover and Deal. A total of 23 people were arrested during twenty raids carried out over three days. The suspects, ranging in age from 17 to 52, have all been charged in connection with the supply of class A drugs.
07 September 2009
Brixton Drug Gang Get Long Sentences
A gang of criminals who ran a lucrative drug dealing network from a car tyre shop in Brixton were sentenced last week to a total of 81 years in prison. Nine men, who were previously convicted of conspiracy to supply class A drugs, appeared at Kingston Crown Court today to hear their sentences.
Brixton Drug Gang Get Long Sentences
A gang of criminals who ran a lucrative drug dealing network from a car tyre shop in Brixton were sentenced last week to a total of 81 years in prison. Nine men, who were previously convicted of conspiracy to supply class A drugs, appeared at Kingston Crown Court today to hear their sentences.
27 October 2010
Cancer Drugs Fund Is £200 Million
A cancer-fighting fund of £200 million a year to help cancer patients get greater access to cancer drugs that their doctors recommend for them was confirmed today by Health Secretary Andrew Lansley.
Cancer Drugs Fund Is £200 Million
A cancer-fighting fund of £200 million a year to help cancer patients get greater access to cancer drugs that their doctors recommend for them was confirmed today by Health Secretary Andrew Lansley.
03 November 2005
Fast-track guidance for life-saving drugs
Patients should be able to receive life-saving drugs more quickly under a new scheme announced by the government. Health Secretary Patricia Hewitt announced proposals to allow the National Institute for Health and Clinical Excellence to produce faster guidance on life-saving drugs.
Fast-track guidance for life-saving drugs
Patients should be able to receive life-saving drugs more quickly under a new scheme announced by the government. Health Secretary Patricia Hewitt announced proposals to allow the National Institute for Health and Clinical Excellence to produce faster guidance on life-saving drugs.
29 July 2010
£50M Fund For Cancer Drugs Announced
Cancer patients are set to get greater access to cancer drugs recommended by their doctors as a result of a new £50 million fund, the government has announced.
£50M Fund For Cancer Drugs Announced
Cancer patients are set to get greater access to cancer drugs recommended by their doctors as a result of a new £50 million fund, the government has announced.
-
Northern Ireland WeatherToday:A showery start with outbreaks most frequent north of Lough Neagh and through the morning, before dwindling during the afternoon as the northwest breezes ease and brighter spells of weak sunshine prosper. Maximum temperature 8 °C.Tonight:A dry night, save for a few light showers around the coasts, with prolonged clear spells and light winds bringing a frosty dawn for many in central and southern parts. Minimum temperature -3 °C.
